Cargando…

Receptor targeting drug delivery strategies and prospects in the treatment of rheumatoid arthritis

Rheumatoid arthritis (RA), a chronic inflammatory disease, is characterized by cartilage damage, bone tissue destruction, morphological changes in synovial fluids, and synovial joint inflammation. The inflamed synovial tissue has potential for passive and active targeting because of enhanced permeab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Emami, Jaber, Ansarypour, Zahra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937749/ https://www.ncbi.nlm.nih.gov/pubmed/32038727 http://dx.doi.org/10.4103/1735-5362.272534

Ejemplares similares

Targeted drug delivery of Methotrexate in situ gels for the treatment of Rheumatoid Arthritis
por: Venkatesh, Madhugiri Prakash, et al.
Publicado: (2020)

Food-Derived Nanoscopic Drug Delivery Systems for Treatment of Rheumatoid Arthritis
por: Han, Dong, et al.
Publicado: (2020)

Applications and recent advances in transdermal drug delivery systems for the treatment of rheumatoid arthritis
por: Xu, Yuyi, et al.
Publicado: (2023)

Transdermal delivery of inflammatory factors regulated drugs for rheumatoid arthritis
por: Zhang, Yanyan, et al.
Publicado: (2022)

Carbon Nanotubes—Potent Carriers for Targeted Drug Delivery in Rheumatoid Arthritis
por: Kofoed Andersen, Camilla, et al.
Publicado: (2021)

Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
por: Mueller, Anna-Lena, et al.
Publicado: (2021)

Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
por: Dayer, Jean-Michel, et al.
Publicado: (2010)

Nano-Based Co-Delivery System for Treatment of Rheumatoid Arthritis
por: Zhang, Shixin, et al.
Publicado: (2022)

Bone-Targeted Delivery of Novokinin as an Alternative Treatment Option for Rheumatoid Arthritis
por: Ranjit, Arina, et al.
Publicado: (2022)

Targeting B cells for the treatment of rheumatoid arthritis
por: Oligino, Thomas J, et al.
Publicado: (2003)

Heterologous expression of a rice metallothionein isoform (OsMTI-1b) in Saccharomyces cerevisiae enhances cadmium, hydrogen peroxide and ethanol tolerance
por: Ansarypour, Zahra, et al.
Publicado: (2017)

Triterpenes as Potential Drug Candidates for Rheumatoid Arthritis Treatment
por: Faustino, Célia, et al.
Publicado: (2023)

Recent advances in nanoparticle-based drug delivery systems for rheumatoid arthritis treatment
por: Nasra, Simran, et al.
Publicado: (2022)

Promising Strategies for Transdermal Delivery of Arthritis Drugs: Microneedle Systems
por: Wang, Jitong, et al.
Publicado: (2022)

Nanopreparations for mitochondria targeting drug delivery system: Current strategies and future prospective
por: Wang, Zhenjie, et al.
Publicado: (2017)

Targeting Nuclear Hormone Receptors: PPARα Agonists as Potential Disease-Modifying Drugs for Rheumatoid Arthritis
por: Shirinsky, Ivan V., et al.
Publicado: (2011)

Targeting Probiotics in Rheumatoid Arthritis
por: Bungau, Simona Gabriela, et al.
Publicado: (2021)

Lipid Nano-System Based Topical Drug Delivery for Management of Rheumatoid Arthritis: An Overview
por: Dhule, Komal Diliprao, et al.
Publicado: (2023)

Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies
por: Liu, Peng, et al.
Publicado: (2021)

New Targets and Strategies for Rheumatoid Arthritis: From Signal Transduction to Epigenetic Aspect
por: Zhu, Menglin, et al.
Publicado: (2023)

Drug-microbiota interactions and treatment response: Relevance to rheumatoid arthritis
por: Sayers, Ellie, et al.
Publicado: (2018)

Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments
por: Chi, Xiao-Kai, et al.
Publicado: (2023)

Lipid-Based Nanoparticles as a Potential Delivery Approach in the Treatment of Rheumatoid Arthritis
por: Chuang, Shih-Yi, et al.
Publicado: (2018)

Modulating co-stimulation: a rational strategy in the treatment of rheumatoid arthritis?
por: Malmström, Vivianne, et al.
Publicado: (2005)

Nanomedicines for the treatment of rheumatoid arthritis: State of art and potential therapeutic strategies
por: Wang, Qin, et al.
Publicado: (2021)

Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol
por: Barnes, Theresa, et al.
Publicado: (2007)

Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems
por: Kydd, Janel, et al.
Publicado: (2017)

The Treatment of Rheumatoid Arthritis
Publicado: (1929)

Future therapeutic targets in rheumatoid arthritis?
por: Cheung, Tommy Tsang, et al.
Publicado: (2017)

Brain tumor-targeted drug delivery strategies
por: Wei, Xiaoli, et al.
Publicado: (2014)

Targeting strategies for delivery of anti-HIV drugs
por: Ramana, Lakshmi Narashimhan, et al.
Publicado: (2014)

Abatacept in the treatment of rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2008)

Etanercept in the treatment of rheumatoid arthritis
por: Haraoui, Boulos, et al.
Publicado: (2007)

Abatacept in the treatment of rheumatoid arthritis
por: Vital, Edward M, et al.
Publicado: (2006)

Infliximab in the treatment of rheumatoid arthritis
por: Perdriger, A
Publicado: (2009)

Abatacept treatment for rheumatoid arthritis
por: Schiff, Michael
Publicado: (2011)

Antibiotics for the treatment of rheumatoid arthritis
por: Ogrendik, Mesut
Publicado: (2013)

Rheumatoid Arthritis and Its Treatment
Publicado: (1932)

The Treatment of Rheumatoid Arthritis and Sciatica
Publicado: (1933)

Drug delivery options to increase patient adherence and satisfaction in the management of rheumatoid arthritis – focus on subcutaneous tocilizumab
por: Nakashima, Yasuharu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gjbdhfucsvu4o0fa8bsep7ak2g